These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 7666847)

  • 21. Access to syringes in three Russian cities: implications for syringe distribution and coverage.
    Sarang A; Rhodes T; Platt L
    Int J Drug Policy; 2008 Apr; 19 Suppl 1():S25-36. PubMed ID: 18313910
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Marketing syringe/needle exchange programs.
    Coleman LJ; Stenlund KJ
    Health Mark Q; 1999; 17(2):67-73. PubMed ID: 11010212
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Residual injection risk behavior, HIV infection, and the evaluation of syringe exchange programs.
    Des Jarlais DC; Braine N; Yi H; Turner C
    AIDS Educ Prev; 2007 Apr; 19(2):111-23. PubMed ID: 17411414
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sterile syringe access conditions and variations in HIV risk among drug injectors in three cities.
    Bluthenthal RN; Malik MR; Grau LE; Singer M; Marshall P; Heimer R;
    Addiction; 2004 Sep; 99(9):1136-46. PubMed ID: 15317634
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Continued risky injection subsequent to syringe exchange use among injection drug users in New York City.
    Paone D; Des Jarlais DC; Caloir S; Jose B; Shi Q; Friedman SR
    AIDS Educ Prev; 1997 Dec; 9(6):505-10. PubMed ID: 9451478
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Injecting yourself in a healthy manner].
    Molina CN; Vidot JV
    Sidahora; 1995; ():15-22. PubMed ID: 11363220
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effectiveness of needle/syringe exchange program in Tbilisi.
    Otiashvili D; Gambashidze N; Kapanadze E; Lomidze G; Usharidze D
    Georgian Med News; 2006 Nov; (140):62-5. PubMed ID: 17179591
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Federal panel endorses needle-exchange programs.
    AIDS Policy Law; 1995 Oct; 10(18):1, 6, 8. PubMed ID: 11362820
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk contexts and risk behaviors in the Euregion Maas-Rhein: the Boule de Neige intervention for AIDS prevention among drug users.
    Franken IH; Kaplan CD
    AIDS Educ Prev; 1997 Apr; 9(2):161-80. PubMed ID: 9167801
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human immunodeficiency virus and hepatitis C virus testing services at syringe exchange programs: availability and outcomes.
    Heinzerling KG; Kral AH; Flynn NM; Anderson RL; Scott A; Gilbert ML; Asch SM; Bluthenthal RN
    J Subst Abuse Treat; 2007 Jun; 32(4):423-9. PubMed ID: 17481466
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Minimal uptake of sterile drug preparation equipment in a predominantly cocaine injecting population: implications for HIV and hepatitis C prevention.
    Morissette C; Cox J; De P; Tremblay C; Roy E; Allard R; Stephenson R; Graves L
    Int J Drug Policy; 2007 May; 18(3):204-12. PubMed ID: 17689367
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heterosexually acquired AIDS--United States, 1993.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1994 Mar; 43(9):155-60. PubMed ID: 8164640
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Secondary syringe exchange among users of 23 California syringe exchange programs.
    Lorvick J; Bluthenthal RN; Scott A; Gilbert ML; Riehman KS; Anderson RL; Flynn NM; Kral AH
    Subst Use Misuse; 2006; 41(6-7):865-82. PubMed ID: 16809176
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Secondary syringe exchange as a model for HIV prevention programs in the Russian Federation.
    Irwin K; Karchevsky E; Heimer R; Badrieva L
    Subst Use Misuse; 2006; 41(6-7):979-99. PubMed ID: 16809182
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Needle-exchange issue put on front burner.
    AIDS Alert; 1997 Jul; 12(7):79-80. PubMed ID: 11364397
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HIV prevalence and risk behaviour in needle exchange attenders: a national study. The Collaboration of Australian Needle Exchanges.
    MacDonald M; Wodak AD; Ali R; Crofts N; Cunningham PH; Dolan KA; Kelaher M; Loxley WM; van Beek I; Kaldor JM
    Med J Aust; 1997 Mar; 166(5):237-40. PubMed ID: 9076266
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Strategies to improve access to sterile syringes for injection drug users.
    Rich JD; Wolf FA; Macalino G
    AIDS Read; 2002 Dec; 12(12):527-35. PubMed ID: 12518719
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clean shots.
    Kaufman G
    Posit Aware; 1995; ():12-3. PubMed ID: 11362203
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Experts ask Senate to ease Federal ban on needle exchange.
    AIDS Policy Law; 1996 Jun; 11(12):5. PubMed ID: 11363575
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Psychosocial and behavioral differences among drug injectors who use and do not use syringe exchange programs.
    Grau LE; Bluthenthal RN; Marshall P; Singer M; Heimer R
    AIDS Behav; 2005 Dec; 9(4):495-504. PubMed ID: 16237501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.